A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be ...

While there’s no cure for pulmonary arterial hypertension (PAH), many types ... any more because there are often newer and better treatment options. Warfarin (Coumadin) thins your blood to ...

A speaker highlighted key advances in the treatment of hypertension in 2024. Topics included insights on the timing of blood pressure medication; impact of bariatric surgery vs. medical therapy on ...

The data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, ...

If your doctor believes you may have renal hypertension or have a higher risk, you can discuss lifestyle and treatment options available to you.

WEST CONSHOHOCKEN, PA — The U.S. Food and Drug Administration (FDA) has approved HemiClor, a 12.5 mg chlorthalidone tablet developed by PRM Pharma, LLC, for the treatment of hypertension in adults.

The treatment will be evaluated by the FDA in the coming months. Bottom line for patients with resistant hypertension The investigators expect the treatment could be offered as an adjunct to ...

Currently, phase 3 studies are under way in Europe that are expected to result in the licensing of inhaled iloprost for the treatment of pulmonary hypertension. With this approach, the options for ...

High-performing countries like Canada and South Korea have delivered comprehensive national hypertension treatment programs, according to WHO, and both nations have surpassed the 50% mark for ...